/PRNewswire/ NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the.
As more women chose to delay childbirth, doctors and health professionals say the option to undergo the procedure should be discussed before the amount and quality of eggs deteriorates
Two Vietnamese edtech startups raised US$16 million in funding last Thursday, marking the latest episode of foreign investment and expansion in the country. - VnExpress International